Stembigen Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Robbins, IL and active since 2011.
Stembigen Pharmaceuticals was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Foster Amoako at the company’s single location by writing to 14004 South Wayman Lane, Robbins, Illinois IL 60472 or by phoning (708) 389-8912. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Stembigen Pharmaceuticals |
| Contact Person: | Foster Amoako |
| Address: | 14004 South Wayman Lane, Robbins, Illinois 60472 |
| Phone Number: | (708) 389-8912 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Stembigen Pharmaceuticals was started in 2011 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Foster Amoako for inquiries that concern Stembigen Pharmaceuticals by calling the company number (708) 389-8912, as your correspondence is most welcome. Additionally, the physical location of the single location of Stembigen Pharmaceuticals can be found at the coordinates 41.638672,-87.701259 as well as the street address 14004 South Wayman Lane in Robbins, Illinois 60472.
For its online presence, you may visit Stembigen Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.